GLI1 and cancer: Combination therapy of chemo drugs or targeting drugs with inhibitors or nucleic acid drugs targeting the GLI1-SOX2OT loop in vivo may further help in identifying novel therapeutic sensitizers for multiple regimens of cancer treatment.